CDEK
← All organizations

Kala Pharmaceuticals, Inc.

For profitWebsite ↗

Also known as: Kala Pharmaceuticals, Inc. | KALA PHARMS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 2014

First marketed drug

Aug 22, 2018

Last known activity

Feb 7, 2023

Timeline

2000s

  1. Jun 1, 2009

    Kala Pharmaceuticals, Inc.— Founded

2010s

  1. Aug 22, 2018

    loteprednol— NDA Secondary Org

Drugs by trial phase (3 distinct, 11 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (12)

Details

Founded
Waltham, Massachusetts, US Jun 1, 2009
Last known activity
Feb 7, 2023